BioCardia (BCDA) Accounts Payables (2010 - 2026)
BioCardia's Accounts Payables was $541,000 in Q2 2026, down 56.1% from $1.23 million a year earlier and down 34.0% from the prior quarter.
Analysis
BioCardia (BCDA) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at BioCardia came in at $641,000, up 66.5% from FY2024.
- Accounts Payables shows a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $385,000 in FY2024 (-56.7%), $890,000 in FY2023 (+30.3%), $683,000 in FY2022 (+34.7%) and $507,000 in FY2021 (-32.0%).
- The Q2 2026 figure marks the lowest quarterly Accounts Payables since Q4 2024.
- Compared with a year earlier, Accounts Payables was higher in four of the last eight quarters, with growth averaging 2.6%.
- The best year-over-year quarter for Accounts Payables over five years was Q2 2024 (growth of 110.9%); the worst was Q4 2024 (a decline of 56.7%).
- Per Business Quant data, BCDA's Accounts Payables in the three quarters before Q2 2026 was $820,000 (Q1 2026), $641,000 (Q4 2025) and $1.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.58 Bn |
| 10 | BioCardia | 11.23 Mn | -1.63 Mn | - | 541,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 541,000.00 |
| Mar 31, 2026 | 820,000.00 |
| Dec 31, 2025 | 641,000.00 |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 818,000.00 |
| Dec 31, 2024 | 385,000.00 |
| Sep 30, 2024 | 569,000.00 |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 890,000.00 |
| Sep 30, 2023 | 507,000.00 |
| Jun 30, 2023 | 686,000.00 |
| Mar 31, 2023 | 861,000.00 |
| Dec 31, 2022 | 683,000.00 |
| Sep 30, 2022 | 887,000.00 |
| Jun 30, 2022 | 999,000.00 |
| Mar 31, 2022 | 764,000.00 |
| Dec 31, 2021 | 507,000.00 |
| Sep 30, 2021 | 846,000.00 |
API Access
BioCardia Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=BCDA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "BCDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=BCDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();